Pro-Life Lawsuit against the state of Illinois

Pro-Life Lawsuit against the State of Illinois

NO HB40
On November 30, 2017, the Thomas More Society filed a taxpayer lawsuit against State of Illinois officials in a counter attack against House Bill 40, which requires public funding of tens of thousands of elective abortions. The taxpayer lawsuit, filed in the Sangamon County Circuit Court, is brought on behalf of hundreds of thousands of Illinois taxpayers, represented by county and statewide pro-life organizations including the Illinois Federation for Right to Life and it's many affiliates.
HB 40 would force every Illinoisan to pay for free abortions for those on Medicaid and state employee health insurance. This would apply through the full nine months of pregnancy and for any reason, even when the latest scientific research has shown that the unborn child can feel pain and survive outside the womb.

The Thomas More society is a not for profit national public interest law firm dedicated to restoring respect in law for life, family, and religious freedom. The Thomas More Society is based in Chicago. Please consider helping the Thomas More Society with your financial support.

March 1, 2017

"Big Abortion" Wants the Dangerous Pregnancy-Destroying Drug Mifepristone (RU-486) Sold in Local Pharmacies

Dr. Thomas Price, Secretary of the Department of Health and Human Services, please take note. Your U.S. Food and Drug Administration (FDA) will soon be cooperating (conspiring) with abortion activists to relax important health regulations so that America’s only approved abortion regimen can be sold by local drug stores. In fact, the process may well be underway as I write.

Big Abortion’s aggressive push for evermore abortion, despite great health concerns for the mother (not to mention the baby), appears to know few bounds. Mifepristone, also known as RU-486, is incontrovertibly an embryo and fetal-destructive chemical. Mifepristone (also, Mifeprex®) blocks the chemical action of progesterone, the key hormone that drives pregnancy forward. Mifepristone is taken with a second drug, misoprostol (Cytotec), which causes uterine-emptying contractions when taken by a pregnant woman. This two-drug abortion regimen was first approved by the FDA in 2000.

There are many details related to the distribution of this regimen, but the key points to note are that access to the mifepristone itself is still pretty tightly controlled. The current 2016 regulations for the mifepristone regimen do not allow it to be sold in pharmacies. Rather, mifepristone may be distributed only by certified healthcare providers (originally, it had to be a physician). Such providers must have the ability to assess the duration of the pregnancy accurately, be able to diagnose ectopic pregnancies, be able to get the patient to surgical intervention in case of an incomplete abortion or severe bleeding, and, finally, must have read the prescribing information about the regimen. Clearly this sort of patient assessment cannot take place at pharmacies. The regimen may not be prescribed after the 70th day of pregnancy (LMP).

Click here for more from the FRC Blog.